Neural Therapeutics, Inc. (NURL.CX)

0.025 0.00 (0.00%) CAD  |  CNSX  |  Dec 05, 16:00
More

Neural Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for NURL.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
BioMark Diagnostics, Inc. Upgrade
Justera Health Ltd. Upgrade
Wesana Health Holdings, Inc. --
Biocure Technology, Inc. Upgrade
Core One Labs, Inc. --